Home › Cancro della vescica › New York
Studi clinici su Cancro della vescica nello stato di New York
41 studi su Cancro della vescica cercano partecipanti presso sedi nello stato di New York.
Città nello stato di New York
- New York City35 studi
- Queens16 studi
- New Rochelle11 studi
- Staten Island11 studi
- Greenburgh10 studi
- Rochester7 studi
- Buffalo5 studi
- Albany4 studi
- The Bronx4 studi
- Syracuse4 studi
Testo ufficiale dello studio (inglese)
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- e altri 2
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06465069KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
- Memorial Sloan Kettering Cancer Center ( Site 5031), New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07232602Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- e altri 3
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07000084Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- e altri 1
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06770582A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0111), New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06833073A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Roswell Park Cancer Institute IDS, Buffalo
- Memorial Sloan Kettering Hospital, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06172478Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- The New York Hospital Medical Center of Queens, Flushing
- NYP/Weill Cornell Medical Center, New York
- Stony Brook University Medical Center, Stony Brook
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07061964Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- e altri 3
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT03866382Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- New York Oncology Hematology, Albany
- New York Oncology Hematology, Clifton Park
- Icahn School of Medicine at Mount Sinai, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07421700A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- MSK Commack, Commack
- MSK Westchester, Harrison
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- e altri 9
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07206225A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Columbia University Irving Medical Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07277413A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
- Memorial Sloan Kettering Cancer Center ( Site 0832), New York
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07419295A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical College, New York
- e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07218380A Study of Surgical Techniques During Cystectomy
- Memorial Sloan Kettering Suffolk-Commack (Consent Only), Commack
- Memorial Sloan Kettering Westchester (Consent Only), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
- e altri 1
In reclutamentoFase 3
Età 21 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06703476A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
- Roswell Park Comprehensive Cancer Center, Buffalo
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT06733363A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 set 2026 · NCT07217171First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT06644755Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Integrated Medical Professionals, PLLC (Solaris), New York
- University of Rochester, Rochester
- SUNY Upstate, Syracuse
- e altri 2
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 set 2026 · NCT06567743A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- e altri 1
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT05837767Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Laura & Isaac Perlmutter Cancer Center - NYU Langone Health, New York
- University of Rochester, Department of Urology, Rochester
- Associated Medical Professionals of NY, PLLC, Syracuse
- e altri 1
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 ago 2026 · NCT05951179FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- New York University (NYU), New York
- Weill Cornell Medicine, New York
- Icahn School of Medicine at Mount Sinai, New York
- e altri 4
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT05614739Measuring Surgical Recovery After Radical Cystectomy
- Winthrop University Hospital, Mineola
- University of Rochester, Rochester
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 19 ago 2026 · NCT03193970Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- e altri 4
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 ago 2026 · NCT07097142A Study of MGC026 in Participants With Advanced Solid Tumors
- START-New York Long Island, Lake Success
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 ago 2026 · NCT06242470LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Albany Medical College, Albany
- Roswell Park Cancer Institute, Buffalo
- Mount Sinai Medical Center, New Haven
- e altri 1
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 7 ago 2026 · NCT04752722A Study of a Side Effects and Resource Navigation Program for People With Cancer
- Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- City College of New York (Data Collection AND Specimen Analysis), New York
- e altri 2
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 31 lug 2026 · NCT07646847Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 lug 2026 · NCT07106762A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 2
Età 8 e oltre · Tutti i sessi · Aggiornato il 27 lug 2026 · NCT05503797An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
- Research Site, Albany
- Research Site, New York
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 lug 2026 · NCT07720284A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- MSK Commack, Commack
- MSK Wesrchester, Harrison
- Memorial Sloan Kattering Cancer Centre- Investigational Drug Service Pharmacy, Long Island City
- e altri 6
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 lug 2026 · NCT04879329A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Brooklyn
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park
- e altri 7
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT04389632Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
- Albany MED Health System, Albany
- Integrated Medical Professionals, New York
- Premier Medical Group of the Hudson Valley, P. C., Poughkeepsie
In reclutamento
Età da 18 a 88 · Tutti i sessi · Aggiornato il 2 lug 2026 · NCT06394869Integrated Cancer Repository for Cancer Research
- C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
- Faxton St. Luke's Healthcare, Mohawk Valley, Utica
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 19 a 110 · Tutti i sessi · Aggiornato il 29 giu 2026 · NCT02012699A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering West Harrison (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- e altri 1
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 apr 2026 · NCT05562791A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 feb 2026 · NCT06778863A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
- University of Rochester Medical Center, Rochester
In reclutamentoStudio osservazionale
Età da 18 a 90 · Tutti i sessi · Aggiornato il 4 feb 2026 · NCT03193541Blue Light Cystoscopy With Cysview® Registry
- NYU Langone's Perlmutter Cancer Center, New York
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 dic 2025 · NCT02660645Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
- Mount Sinai Hospital, New York
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 dic 2025 · NCT06689176SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Buffalo
- Massive Bio SYNERGY-AI site, Hempstead
- Massive Bio SYNERGY-AI site, Manhasset
- e altri 2
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 28 ott 2025 · NCT03452774Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.